RCEL
AVITA Medical Inc
Price:
6.52
USD
Volume:
173,393
United States | Biotechnology
AVITA Gross Margin
As of 2025-05-21, the Gross Margin of AVITA Medical Inc (RCEL) is 86.6%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
AVITA Gross Margin - Historical Value
| Date | Value |
|---|---|
| 2024-12-31 | 86.6% |
| 2023-12-31 | 84.9% |
| 2022-12-31 | 83.5% |
| 2021-12-31 | 86.7% |
| 2021-06-30 | 80.4% |
| 2020-06-30 | 81.3% |
| - | |
| - | |
| - | |
| - |
AVITA Gross Margin - Peers Comparison